Aditya Pratap Singh,
Akanksha Dwivedi,
G.N. Darwhekar,
- Student, Department of Pharmaceutics, Acropolis Institute of Pharmaceutical Education and Research, Indore, Madhya Pradesh, India
- Associate Professor, Department of Pharmaceutics, Acropolis Institute of Pharmaceutical Education and Research, Indore, Madhya Pradesh, India
- Principal, Department of Pharmacy, Acropolis Institute of Pharmaceutical Education and Research, Indore, Madhya Pradesh, India
Abstract
The revolutionary potential of artificial intelligence (AI) is examined in this essay the pharmaceutical industry, highlighting its application across the drug development lifecycle. Artificial Intelligence, specifically via deep learning models and machine learning (ML) such as GANs, RNNs, and transformers, enhances drug discovery, formulation, toxicity prediction, and clinical trials. It streamlines processes like identification of targets, virtual screening, modelling of structure-activity relationships, and medication repurposing. AI is also employed in optimizing formulations for controlled and immediate release tablets, capsules, and advanced drug delivery systems. Despite its possibilities, obstacles like data availability, model interpretability, and lack of clinical expertise remain. The article concludes that AI has already demonstrated significant impact in pharmaceutical R&D and is poised to further revolutionize personalized medicine, improve patient outcomes, and accelerate innovation in the sector.
Keywords: Artificial Intelligence, Machine learning, Drug discovery, formulation challenge, AI in pharmaceutical business.
[This article belongs to Research & Reviews: A Journal of Drug Design & Discovery ]
Aditya Pratap Singh, Akanksha Dwivedi, G.N. Darwhekar. Accelerating Drug Discovery with AI: Transforming the Pharmaceutical Pipeline. Research & Reviews: A Journal of Drug Design & Discovery. 2025; 12(02):-.
Aditya Pratap Singh, Akanksha Dwivedi, G.N. Darwhekar. Accelerating Drug Discovery with AI: Transforming the Pharmaceutical Pipeline. Research & Reviews: A Journal of Drug Design & Discovery. 2025; 12(02):-. Available from: https://journals.stmjournals.com/rrjoddd/article=2025/view=0
References
- Singh D, Singh R, Gehlot A, Akram SV, Priyadarshi N, Twala B. An imperative role of digitalization in monitoring cattle health for sustainability. Electronics. 2022 Aug 29;11(17):2702.
- Kalyane D, Sanap G, Paul D, Shenoy S, Anup N, Polaka S, Tambe V, Tekade RK. Chapter 3 – Artificial intelligence in the pharmaceutical sector: current scene and future prospect. In The future of pharmaceutical product development and research 2020 Jan 1 (pp. 73-107). Academic Press https://doi.org/10.1016/B978-0-12-814455-8.00003-7 .
- Paul D, Sanap G, Shenoy S, Kalyane D, Kalia K, Tekade RK. Artificial intelligence in drug discovery and development. Drug Discov Today. 2021 Jan;26(1):80-93. doi: 10.1016/j.drudis.2020.10.010.
- Landin M, Rowe RC. Artificial neural networks technology to model, understand, and optimize drug formulations. Formulation tools for pharmaceutical development 2013 Jan 1 (pp. 7-37). Woodhead Publishing https://doi.org/10.1533/9781908818508.7 .
- Gao M, Liu S, Chen J, Gordon KC, Tian F, McGoverin CM. Potential of Raman spectroscopy in facilitating pharmaceutical formulations development–an AI perspective. International journal of pharmaceutics. 2021 Mar 15;597:120334 https://doi.org/10.1016/j.ijpharm.2021.120334 .
- Sousa T, Correia J, Pereira V, Rocha M. Generative deep learning for targeted compound design. Journal of chemical information and modeling. 2021 Oct 26;61(11):5343-61.
- Rajalingham R, Piccato A, Jazayeri M. Recurrent neural networks with explicit representation of dynamic latent variables can mimic behavioral patterns in a physical inference task. Nature Communications. 2022 Oct 4;13(1):5865.
- Huo, L., & Tang, Y. (2023). Multi-Objective Deep Reinforcement Learning for Personalized Dose Optimization Based on Multi-Indicator Experience Replay. Applied Sciences, 13(1), 325. https://doi.org/10.3390/app13010325
- Turchin A, Masharsky S, Zitnik M. Comparison of BERT implementations for natural language processing of narrative medical documents. Informatics in Medicine Unlocked. 2023 Jan 1;36:101139 https://doi.org/10.1016/j.imu.2022.101139 .
- Duch W, Swaminathan K, Meller J. Artificial intelligence approaches for rational drug design and discovery. Current pharmaceutical design. 2007 May 1;13(14):1497-508.
- Shah H, Chavda V, Soniwala MM. Applications of bioinformatics tools in medicinal biology and biotechnology. Bioinformatics tools for pharmaceutical drug product development. 2023 Feb 27:95-116 https://doi.org/10.1002/9781119865728.ch6 .
- Mishra V. Artificial intelligence: the beginning of a new era in pharmacy profession. Asian Journal of Pharmaceutics (AJP). 2018 May 30;12(02) DOI:https://doi.org/10.22377/ajp.v12i02.2317
- Guo M, Kalra G, Wilson W, Peng Y, Augsburger LL. A prototype intelligent hybrid system for hard gelatin capsule formulation development. Pharmaceutical technology. 2002 Sep 1:44-52.
- Al Kuwaiti A, Nazer K, Al-Reedy A, Al-Shehri S, Al-Muhanna A, Subbarayalu AV, Al Muhanna D, Al-Muhanna FA. A review of the role of artificial intelligence in healthcare. Journal of personalized medicine. 2023 Jun 5;13(6):951.
- Hamet P, Tremblay J. Artificial intelligence in medicine. metabolism. 2017 Apr 1;69:S36-40.
- Hughes JP, Rees S, Kalindjian SB, Philpott KL. Principles of early drug discovery. British journal of pharmacology. 2011 Mar;162(6):1239-49.
- Mishra V. Artificial intelligence: the beginning of a new era in pharmacy profession. Asian Journal of Pharmaceutics (AJP). 2018 May 30;12(02).
- Gursoy RN, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomedicine & pharmacotherapy. 2004 Apr 1;58(3):173-82.
- Vu GT, Phan NT, Nguyen HT, Nguyen HC, Tran YT, Pham TB, Nguyen LT, Nguyen HD. Application of the artificial neural network to optimize the formulation of self-nanoemulsifying drug delivery system containing rosuvastatin. Journal of Applied Pharmaceutical Science. 2020 Sep 4;10(9):001-11.
- Labouta HI, El-Khordagui LK, Molokhia AM, Ghaly GM. Multivariate modeling of encapsulation and release of an ionizable drug from polymer microspheres. Journal of pharmaceutical sciences. 2009 Dec 1;98(12):4603-15.
- Kiseleva A, Kotzinos D, De Hert P. Transparency of AI in healthcare as a multilayered system of accountabilities: between legal requirements and technical limitations. Frontiers in artificial intelligence. 2022 May 30; vol 5:879603 https://doi.org/10.3389/frai.2022.879603 .
- Kelly CJ, Karthikesalingam A, Suleyman M, Corrado G, King D. Key challenges for delivering clinical impact with artificial intelligence. BMC medicine. 2019 Dec;17:1-9.
- Davenport T, Kalakota R. The potential for artificial intelligence in healthcare. Future healthcare journal. 2019 Jun 1;6(2):94-8.
- Johnson KB, Wei WQ, Weeraratne D, Frisse ME, Misulis K, Rhee K, Zhao J, Snowdon JL. Precision medicine, AI, and the future of personalized health care. Clinical and translational science. 2021 Jan;14(1):86-93.
- Zeeshan Ahmed, Khalid Mohamed, Saman Zeeshan, XinQi Dong, Artificial intelligence with multi-functional machine learning platform development for better healthcare and precision medicine, Database, Volume 2020, 2020, baaa010, https://doi.org/10.1093/database/baaa010

Research & Reviews: A Journal of Drug Design & Discovery
| Volume | 12 |
| Issue | 02 |
| Received | 08/06/2025 |
| Accepted | 26/06/2025 |
| Published | 01/08/2025 |
| Publication Time | 54 Days |
[first_name] [last_name]